Menu

Blog

Archive for the ‘life extension’ category: Page 445

Oct 15, 2018

How Inclusive Capitalism, Technology And Social Prescribing Could Reverse Flagging Life Expectancy

Posted by in categories: economics, life extension

Hard as it is to believe, for the first time the life expectancy for Americans (not counting the effect of wars) has https://www.ajc.com/lifestyles/health/cdc-life-expectancy-de…279HCufnO/” target=”_blank” rel=” nofollow noopener noreferrer” data-ga-track=” ExternalLink: https://www.ajc.com/lifestyles/health/cdc-life-expectancy-de…279HCufnO/”>dropped for two consecutive years. Perhaps less hard to believe is that this is https://news.harvard.edu/gazette/story/2016/04/for-life-expe…y-matters/” target=”_blank” rel=” nofollow noopener noreferrer” data-ga-track=” ExternalLink: https://news.harvard.edu/gazette/story/2016/04/for-life-expe…y-matters/”>not true across economic levels. The richest Americans are gaining in longevity, indeed to unprecedented levels. The poor don’t have it so well, and in the U.S., this includes the shrinking middle class, who are also dying earlier. With the widening income gap, there’s a growing discrepancy between life expectancies for the rich and poor. Depending on geography, those on the lower end of the income bracket spread can expect to live 20 years less than their better-off counterparts, a shocking finding from an http://jamanetwork.com/journals/jamainternalmedicine/fullart.…2017.0918” target=”_blank” rel=” nofollow noopener noreferrer” data-ga-track=” ExternalLink: http://jamanetwork.com/journals/jamainternalmedicine/fullart.…2017.0918”>in-depth study coming out of the University of Washington.

Read more

Oct 15, 2018

The Potential of Thymus Regeneration

Posted by in categories: biotech/medical, life extension

Intervene Immune is a company focused on the age-related decline of the immune system, which is known as immunosenescence. Here, Bobby Brooke, CEO of Intervene Immune, discusses the clinical potential of regenerating the thymus as a means of reversing age-related immune system decline.


Earlier this year, we hosted the Ending Age-Related Diseases 2018 conference at the Cooper Union, New York City. This was a conference designed to bring together the best in the aging research and biotech investment worlds and saw a range of industry experts sharing their insights.

Continue reading “The Potential of Thymus Regeneration” »

Oct 13, 2018

Life Extension & Human Longevity with Dr. Aubrey de Grey on MIND & MACHINE

Posted by in categories: biotech/medical, computing, life extension

https://www.youtube.com/watch?v=68XOEAfMj_A&feature=share

New Aubrey interview.


Today we explore human longevity and life extension efforts focused on adding healthy years to a person’s lifespan, and even reversing the aging process.

Continue reading “Life Extension & Human Longevity with Dr. Aubrey de Grey on MIND & MACHINE” »

Oct 13, 2018

Introducing the NAD+ Mouse Project

Posted by in category: life extension

Can we delay or even reverse the aging process? The scientists at the Sinclair Lab at Harvard Medical School think so, and you can help them find out!

https://www.lifespan.io/nmn

So far the NAD+ Mouse Project by Dr. David Sinclair and his team at Harvard Medical School has raised over $43,265 for an exciting research project that is targeting the aging process. Help us reach $45,000 so we can expand the project even more.

Read more

Oct 13, 2018

‘Your Blood Will Freeze’: How Foreigners Seek Immortality in Russia

Posted by in categories: biotech/medical, life extension, transhumanism

Sputnik’s interlocutor has a medallion with a phone number and instructions for what to do if he dies. So it’s highly likely that if he dies he will end up where he and Sputnik have come.

Freeze Your Own Grandma

Continue reading “‘Your Blood Will Freeze’: How Foreigners Seek Immortality in Russia” »

Oct 11, 2018

The First Therapy that Targets Aging is in Human Trials Now

Posted by in categories: biotech/medical, life extension

https://youtube.com/watch?v=6A1knkZiysQ

Senolytics are the first therapies that directly target the aging process to delay or prevent age-related diseases and are now in human trials. Today we thought it was the ideal time to have a look at how they work and the companies involved.

Senescent cells and aging

Continue reading “The First Therapy that Targets Aging is in Human Trials Now” »

Oct 11, 2018

Cellular Senescence — Why we Age

Posted by in categories: biotech/medical, life extension

As we get older, more and more of our the cells in our bodies become dysfunctional and enter into a state known as senescence. These senescent cells no longer divide or support the tissues and organs of which they are part; instead, they secrete a range of harmful inflammatory chemical signals, which are known as the senescence-associated secretory phenotype (SASP).

For more aging research news visit: https://www.leafscience.org/

Read more

Oct 10, 2018

Longevity World Forum

Posted by in categories: life extension, policy

1st conference upcoming in Nov. 2018, in Spain.


Cookies Policy This site uses cookies for you to have the best user experience. If you continue to browse you are giving your consent to the acceptance of the aforementioned cookies and acceptance of our cookies policy, click the link for more information.

Read more

Oct 10, 2018

Aging Happens

Posted by in categories: biotech/medical, law, life extension

Today, we have a talk by Dr. Alvaro Macieira-Coelho, who discusses how aging is a consequence of thermodynamics and entropy. Quite simply, aging is the default for most species.

Earlier this year, we hosted the Ending Age-Related Diseases 2018 conference at the Cooper Union, New York City. The event was focused on bringing the worlds of research and investment in the rejuvenation biotechnology field together and saw a number of talks and panels focused on research and investment.

Continue reading “Aging Happens” »

Oct 9, 2018

Reason and Bill Cherman – Investing in Longevity

Posted by in categories: biotech/medical, life extension

Here at LEAF, we engage in a wide range of activities in support of the development of rejuvenation biotechnology in order to end age-related diseases. We report the latest news in aging research, attend conferences and give talks, educate, advocate, and fundraise for research projects on Lifespan.io; recently, we implemented the Longevity Investor Network in order to bring startup companies and investors together.

The Longevity Investor Network

The Longevity Investor Network is a group of investors who meet every month and invite young biotech companies working on aging to pitch their ideas. A successful pitch can often mean funding for a new startup company, helping to get its product developed and into clinical trials.

Read more